Palm Therapeutics develops small-molecule therapies for currently untreatable diseases by targeting protein palmitoylation, an essential modulator of disease progression. The company’s technology allows for the development of uniquely potent and protein-selective small molecule palmitoylation inhibitors. Drug-induced selective depalmitoylation makes it possible to inhibit proteins that couldn’t previously be targeted.
Location: United States, California, San Diego
Investors 2
| Date | Name | Website |
| 08.07.2022 | Creative D... | creativede... |
| 01.02.2024 | Tachyon Ve... | tachyon.vc |